The ever-deepening bond between humans and companion animals fuels a surge in the Global Companion Animal Drugs Industry. According to a recent industry report, the market is anticipated to reach a remarkable US$59.2 billion by 2033, propelled by a robust Compound Annual Growth Rate (CAGR) of 4.4%. This translates to a significant increase from the US$36.7 billion recorded in 2022, highlighting …
Tag Archives: Global Companion Animal Drugs
Global Companion Animal Drugs Industry Is Expected to Grow at a 4.4% CAGR to Reach US$ 59.2 Billion by 2033, Per FMI Analysis | FMI
The bond between humans and companion animals continues to strengthen, driving a surge in the Global Companion Animal Drugs Industry. According to a recent industry report, the market is projected to experience a robust Compound Annual Growth Rate (CAGR) of 4.4%, reaching a staggering US$ 59.2 billion by 2033. This signifies a significant leap from …
Global Companion Animal Drugs Industry Set to Reach US$ 59.2 Billion by 2033, FMI Analysis Reveals 4.4% CAGR | FMI
The Global Companion Animal Drugs Industry is embarking on an impressive growth journey, with projections indicating a robust 4.4% Compound Annual Growth Rate (CAGR). By 2033, the industry is anticipated to achieve a substantial market valuation of US$ 59.2 billion, a significant leap from the US$ 36.7 billion recorded in 2022. Companion animals, including beloved …
Global Companion Animal Drugs Industry to Attain US$ 59.2 Billion by 2033 at 4.4% CAGR | FMI Analysis
The Global Companion Animal Drugs Industry is on a steadfast growth trajectory, projected to attain a remarkable 4.4% Compound Annual Growth Rate (CAGR), ultimately reaching a substantial market valuation of US$ 59.2 billion by the close of 2033, compared to the US$ 36.7 billion recorded in 2022. Companion animals, including beloved pets such as dogs, …